Video 1/3 in our series with Dr Sharon Tate.
Two thirds of UK women with ovarian cancer are diagnosed late when the cancer has spread and is difficult to treat. IMI spoke to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC) to find out more
Read more here - www.pharmacyupdate.online/ova...
Register on our website for news straight to your inbox - www.pharmacyupdate.online/sig...
Watch the full series on RU-vid - • In Discussion With - D...
Or our website - www.pharmacyupdate.online/cat...
0:00 - Introduction, titles & roles
0:27 - What do we need to know about ovarian cancer?
2:17 - What are the symptoms?
3:44 - Why is late diagnosis common?
This interview was recorded on 02.03.22.
___
Keep up to date with us across our network;
Email us at - info@medicalimi.com
Site - pharmacyupdate.online
Twitter - / pharmacyupdateo
Facebook - / pharmacyupdateonline
LinkedIn - / pharmacyupdateonline
This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2021 PharmacyUpdateOnline.
IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries.
IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc.
It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond.
To find out more about IMI, please see our websites www.pharmacyupdate.online and www.medicalimi.com. Alternatively, you can email us at info@medicalimi.com.
4 авг 2024
